Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer

ClinicalTrials.gov ID: NCT01358877

Public ClinicalTrials.gov record NCT01358877. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 3:23 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Multicenter, Double-Blind, Placebo-Controlled Comparison of Chemotherapy Plus Trastuzumab Plus Placebo Versus Chemotherapy Plus Trastuzumab Plus Pertuzumab as Adjuvant Therapy in Patients With Operable HER2-Positive Primary Breast Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This randomized, double-blind, placebo-controlled, two-arm study will assess the safety and efficacy of pertuzumab in addition to chemotherapy plus trastuzumab as adjuvant therapy in participants with operable HER2-positive primary breast cancer. This study will be carried out in collaboration with the Breast International Group (BIG).

Study identification

NCT ID
NCT01358877
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
4,804 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 8, 2011 (Actual)
Primary completion
Dec 19, 2016 (Actual)
Completion
Nov 28, 2024 (Actual)
Last update posted
Nov 28, 2025

2011 – 2024

United States locations

U.S. sites
114
U.S. states
36
U.S. cities
95
Facility City State ZIP Site status
HonorHealth Research Institute ? Bisgrove Scottsdale Arizona 85258 —
Providence Regional Medical Center Everett California 98208 —
Marin Cancer Care Inc Greenbrae California 94904 —
Kaiser Permanente - Hayward Hayward California 94545 —
UCSD Moores Cancer Center La Jolla California 92093 —
Cedars-Sinai Medical Center Los Angeles California 90048 —
Kaiser Permanente - Oakland Oakland California 94611 —
Kaiser Permanente - Roseville Roseville California 95661 —
Sutter Cancer Center Sacramento California 95816 —
Kaiser Permanente Sacramento Medical Center Sacramento California 95825 —
Southern California Kaiser Permanente San Diego California 92108 —
K. Permanente - San Fransisco San Francisco California 94115 —
K. Permanente - San Jose San Jose California 95119 —
K. Permanente - Santa Clara Santa Clara California 95051 —
K. Permanente - S. San Fran South San Francisco California 94080 —
Kaiser Permanente Vallejo California 94589 —
K. Permanente - Walnut Creek Walnut Creek California 94596 —
Rocky Mountain Cancer Center - Denver Denver Colorado 80220 —
Lutheran Hematology &Oncology Wheat Ridge Colorado 80033 —
Eastern Ct Hema/Onco Assoc Norwich Connecticut 06360 —
Washington Cancer Institute at MedStar Washington Hospital Center. Washington D.C. District of Columbia 20010 —
Georgetown U Washington D.C. District of Columbia 20057 —
Florida Cancer Specialists Fort Myers Florida 33916 —
Memorial Cancer Institute Hollywood Florida 33021 —
Mayo Clinic-Jacksonville Jacksonville Florida 32224 —
Cancer Specialists Jacksonville Florida 32256 —
Ocala Oncology Center Ocala Florida 34474 —
Memorial Breast Cancer Center Pembroke Pines Florida 33028 —
Hematology Oncology Associates of the Treasure Coast Port Saint Lucie Florida 34952 —
Florida Cancer Specialists St. Petersburg Florida 33705 —
Florida Cancer Specialists, Research Department West Palm Beach Florida 33401 —
Phoebe Putney Memorial Hospital Albany Georgia 31701 —
Georgia Cancer Specialists Atlanta Georgia 30341 —
Northwest Georgia Oncology Centers PC - Marietta Marietta Georgia 30060 —
Kootenai Cancer Center Post Falls Idaho 83854 —
Rush University Medical Center Chicago Illinois 60612 —
Uni of Chicago Chicago Illinois 60637 —
Ingalls Memorial Hospital Harvey Illinois 60426 —
Loyola University Med Center Maywood Illinois 60153 —
Edward Cancer Center Naperville Naperville Illinois 60540 —
Illinois Cancer Care Peoria Illinois 61615-7828 —
Edward Cancer Center Plainfield Plainfield Illinois 60585 —
Quincy Medical Group Quincy Illinois 62301 —
Carle Foundation Urbana Illinois 61801 —
University of Iowa Iowa City Iowa 52242 —
Cancer Center of Kansas Wichita Kansas 67214-3728 —
Cancer Center of Acadiana at Lafayette General Lafayette Louisiana 70503 —
Cancer Care of Maine Bangor Maine 04401 —
New England Cancer Specialists Scarborough Maine 04074 —
Mercy Medical Center Baltimore Maryland 21202 —
Weinberg CA Inst Franklin Sq Baltimore Maryland 21237 —
Maryland Oncology & Hematology, PA Bethesda Maryland 20817 —
Massachusetts General Hospital. Boston Massachusetts 02114 —
Boston Medical Center Boston Massachusetts 02118 —
Beth Israel Deac Med Ctr Boston Massachusetts 02215 —
Dana Farber Can Ins Boston Massachusetts 02215 —
Berkshire Hematology, Oncology Pc Pittsfield Massachusetts 01201 —
Grand Rapids Clinical Oncology Program Grand Rapids Michigan 49503 —
West Michigan Cancer Center Kalamazoo Michigan 49007 —
Southdale Cancer Clinic Edina Minnesota 55414 —
Coborn Cancer Center Saint Cloud Minnesota 56303 —
Metro-Minnesota Community Oncology Research Consortium Saint Louis Park Minnesota 55416 —
Jackson Oncology Associates, PLLC Jackson Mississippi 39202 —
Washington University School of Medicine St Louis Missouri 63110 —
Heartland CCOP/Missouri Baptist Medical Center St Louis Missouri 63131 —
Cancer Alliance of Nebraska Lincoln Nebraska 68510 —
Cancer Alliance of Nebraska Omaha Nebraska 68106 —
Dartmouth Hitchcock Med Center Lebanon New Hampshire 03756 —
Saint Barnabas Medical Center Livingston New Jersey 07039 —
New York Oncology Hematology, P.C. Albany New York 12206 —
Roswell Park Cancer Inst. Buffalo New York 14263 —
Mount Sinai Beth Israel Medical Center New York New York 10003 —
Mount Sinai Beth Israel Comprehensive Cancer Center New York New York 10011 —
Mount Sinai West New York New York 10019 —
Memorial Sloan Kettering Cancer Center New York New York 10065 —
SUNY Upstate Medical University Syracuse New York 13210 —
Montefiore Medical Center The Bronx New York 10467 —
University of North Carolina-Chapel Hill Chapel Hill North Carolina 27599 —
Carolina Oncology Specialists, PA - Hickory Hickory North Carolina 28602 —
Oncology Hematology Care Inc Cincinnati Ohio 45242 —
The Mark H. Zangmeister Ctr Columbus Ohio 43219 —
Dayton Clinical Oncology Prog Dayton Ohio 45420 —
Toledo Clinic Cancer Center Toledo Ohio 43623-3536 —
Northwest Cancer Specialists - Portland (NE Hoyt St) Portland Oregon 97213 —
Abramson Cancer Center Philadelphia Pennsylvania 19104 —
Albert Einstein Healthcare Network Philadelphia Pennsylvania 19141 —
Magee Womens Hospital Pittsburgh Pennsylvania 15213 —
Charleston Oncology, P .A Charleston South Carolina 29414 —
Roper Bon Secours St. Francis Cancer Center Charleston South Carolina 29414 —
South Carolina Oncology Associates - SCRI Columbia South Carolina 29210 —
University of Missouri-Columbia Columbia South Carolina 65203 —
Cancer Centers of the Carolina Greenville South Carolina 29615 —
Sanford USD School of Medicine Sioux Falls South Dakota 57104 —
Tennessee Oncology , PLLC - Chattanooga Chattanooga Tennessee 37403 —
Tennessee Oncology - Nashville Nashville Tennessee 37203 —
Vanderbilt Breast Center at One Hundred Oaks Nashville Tennessee 37204 —
Texas Oncology-Medical City Dallas Dallas Texas 75230 —
Texas Oncology - DFW at Dallas Presbyterian Hospital Dallas Texas 75231 —
Texas Oncology - DFW Dallas Texas 75246 —
Texas Oncology-El Paso Cancer Treatment Center Grandview El Paso Texas 79902 —
Texas Oncology - DFW Fort Worth Fort Worth Texas 76104 —
The Center for Cancer and Blood Disorders - Fort Worth Fort Worth Texas 76104 —
Texas Oncology, P.A. - Garland Garland Texas 77060 —
Texas Oncology - Houston (Gessner) Houston Texas 77024 —
Cancer Care Centers of South Texas-HOAST - San Antonio New Braunfels Texas 78130 —
Texas Oncology - DFW Plano Plano Texas 75075 —
Texas Oncology-Tyler Tyler Texas 75702 —
Community Cancer Trials of Utah Ogden Utah 84405 —
Wellmonth Physician Services Bristol Virginia 24201 —
Virginia Cancer Institute Richmond Virginia 23230 —
Providence St. Mary Regional Cancer Center Walla Walla Washington 99362 —
West Virginia University Hospitals Inc Morgantown West Virginia 26506-9162 —
Green Bay Oncology/St. Mary?s Hospital Green Bay Wisconsin 54301 —
Marshfield Clinic Marshfield Wisconsin 54449 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 432 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01358877, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 28, 2025 · Synced Nov 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01358877 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →